Cardiovascular Diseases
Conditions
Brief summary
The registry study aims to discover the prognostic value of bio-markers in mitral valve disease
Detailed description
The purpose of this study is to investigate the prognostic value of biomarkers in mitral valve disease.Patients with confirmed diagnosis of mitral valve disease are enrolled.The primary outcome is all-cause mortality based on the death certificates. The secondary outcome is readmission for heart failure and all-cause mortality/readmission for heart failure according to the patients' medical records.
Interventions
None listed
Sponsors
Chinese PLA General Hospital
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Inclusion criteria
* Patients clinically diagnosed with mitral valve disease in Beijing Anzhen Hospital from April 2016 to December 2019 * The operator performs more than 25 mitral valve operations per year / the operator unit has surgeons who complete 50 operations per year
Exclusion criteria
* Age ≤ 18 years * Failure to obtain medical records and ultrasound data * Refuse follow-up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of death (all cause) | 1 years of follow-up | Number of death within 2 years of discharge |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of rehospitalizations | 1 years of follow-up | Number of heart failure related hospitalization within 1 years of discharge |
Countries
China
Contacts
Primary ContactYuan Wang, Dr
Backup ContactNing Zhou, Dr
Outcome results
None listed